期刊文献+

干预措施在Ⅰ类切口手术围术期抗菌药物预防应用中的效果评价 被引量:11

Evaluation on effect of intervention on the perioperative antibiotics prophylactic in typeⅠincision operation
下载PDF
导出
摘要 目的评价干预措施促进Ⅰ类切口手术围术期抗菌药物预防性合理应用的有效性和可行性。方法采用回顾性调查方法,抽取东莞康华医院普外科甲状腺手术、腹股沟疝修补术、浅表肿物切除术3种I类切口手术所有病例,干预前105例作为对照组,干预后139例作为干预组,调查分析抗菌药物预防性应用情况。结果与对照组相比,干预组抗菌药物预防使用率从100.00%降至35.25%(P<0.05),品种选择、给药时机等指标合理性显著提高(P<0.05),而术后切口感染率两组差异无统计学意义(P>0.05)。结论干预措施有效可行,能够提高围术期预防性应用抗菌药物的合理性。 Objective To evaluate the effectiveness and feasibility of intervention on perioperative antibiotics prophy laxis in typeⅠincision operations.Methods A retrospective survey was conducted.Patients underwent 3 kinds of type Ⅰincision operations(thyroid surgery,inguinal hernia repair and superficial neoplasm resection) in General Surgery Department of Dongguan Kanghua Hospital were selected.105 cases before intervention were sampled as control group and 139 cases after intervention were sampled as intervention group.Investigation and analysis were performed in the perioperative antibiotics prophylaxis.Results Compared with control group,the intervention group antibiotics prophy laxis usage rate decreased from 100.00% to 35.25%(P 0.05).Rationalities of drug selection and administration time in the intervention group significantly increased(P 0.05).However,postoperative wound infection rate had no significant difference between the two groups(P 0.05).Conclusion Implementation of effective and feasible interventions can promote the rational use of perioperative prophylactic antibiotics.
出处 《中国医药导报》 CAS 2013年第23期109-111,共3页 China Medical Herald
基金 江苏省自然科学基金(编号BK2010017)
关键词 抗菌药物 围术期 干预 Antibiotics Perioperative Intervention
  • 相关文献

参考文献10

二级参考文献26

  • 1吴永佩,颜青.试论医院药事管理学的发展(七)[J].中国药房,2005,16(3):182-184. 被引量:20
  • 2王淑洁,徐燕侠,王海莲,王育琴,陈莲珍,王力红,姜萍,石海鸥,张京利.妇科围手术期抗菌药物合理应用的干预对照研究[J].中华医院感染学杂志,2005,15(7):795-798. 被引量:51
  • 3鲍嫘,袁江英,应群华,马雪莲.妇产科医院感染病原菌分布特点及耐药性分析[J].中华医院感染学杂志,2006,16(6):717-718. 被引量:18
  • 4王贺,徐英春,陈民钧.细菌质粒介导的喹诺酮类抗菌药物耐药机制研究进展[J].中华医院感染学杂志,2007,17(5):618-620. 被引量:151
  • 5Bond CA, Raehl CL. 2006 national clinical pharmacy ser- vices survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy tech- nology[J]. Pharmaeotherapy, 2008,28( 1 ) : 1.
  • 6Shlaes DM,Gerding DN,John JF Jr. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance:Guidelines for the prevention of antimicrobial resistance in hospitals[J].Clinical Infectious Diseases,1997,(03):584-599.
  • 7Javis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls:The complexity of the problem[J].Infection Control and Hospital Epidemiology,1996,(08):490-495.
  • 8Forrest A,Nix DE,Ballow CH. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients[J].Antimicrobial Agents and Chemotherapy,1993,(05):1073-1081.
  • 9Hyatt JM,Scbentag JJ. Potential role of pharmacokinetics,pharmacodynamics,and computerized databases in controlling bacterial resistance[J].Infection Control and Hospital Epidemiology,2000,(1Suppl):S18-S21.
  • 10Blaser J,Stone BB,Groner MC. Comparative study with enoxacin and netilimicin in a pharmacodynamic model to determine importance of ratio and antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance[J].Antimicrobial Agents and Chemotherapy,1987,(07):1054-1060.

共引文献179

同被引文献70

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部